DOCSLIB.ORG

Control of Mammary Tumor Differentiation by SKI-606 (Bosutinib)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Control of Mammary Tumor Differentiation by SKI-606 (Bosutinib) Oncogene (2011) 30, 301–312 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE Control of mammary tumor differentiation by SKI-606 (bosutinib) L Hebbard1,7,9, G Cecena1,7, J Golas2,8, J Sawada3,7, LG Ellies4, A Charbono1,7, R Williams1,7, RE Jimenez5, M Wankell1,7, KT Arndt2,8, SQ DeJoy2,8, RA Rollins2,8, V Diesl2,8, M Follettie2,8, LChen2,8, E Rosfjord2,8, RD Cardiff6, M Komatsu3,7, F Boschelli2,8 and RG Oshima1,7 1Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA; 2Center for Integrative Biology and Biotherapeutics, Pfizer Research, Pearl River, NY, USA; 3Sanford-Burnham Medical Research Institute, Lake Nona, FL, USA; 4Pathology Department, University of California, San Diego, CA, USA; 5Biomedical Science Program, University of California, San Diego, La Jolla, CA, USA and 6Center for Genomic Pathology University of California, Davis, CA, USA C-Src is infrequently mutated in human cancers but it Introduction mediates oncogenic signals of many activated growth factor receptors and thus remains a key target for cancer In breast cancer, Src is of particular interest as it is therapy. However, the broad function of Src in many cell activated by both steroid hormone receptors and ErbB types and processes requires evaluation of Src-targeted family growth factor receptors and activates transcrip- therapeutics within a normal developmental and immune- tion factors such as STAT3, STAT5 and b-catenin by competent environment. In an effort to understand the direct phosphorylation (Silva and Shupnik, 2007; Kim appropriate clinical use of Src inhibitors, we tested an Src et al., 2009). Cellular Src was discovered in 1978 as the inhibitor, SKI-606 (bosutinib), in the MMTV-PyVmT cellular counterpart of a viral gene, n-src, the transform- transgenic mouse model of breast cancer. Tumor forma- ing agent of Rous sarcoma virus (Spector et al., 1978). tion in this model is dependent on the presence of Src, but This non-receptor tyrosine kinase belongs to a family of the necessity of Src kinase activity for tumor formation proteins that mediate signaling by a large number of has not been determined. Furthermore, Src inhibitors have growth factor receptors, integrins, G-protein-coupled not been examined in an autochthonous tumor model that receptors, hormones and stress responses implicated in permits assessment of effects on different stages of tumor multiple types of cancer and vascular biology (Criscuoli progression. Here we show that oral administration of et al., 2005; Summy and Gallick, 2006; Kim et al., 2009). SKI-606 inhibited the phosphorylation of Src in mammary Src is over-expressed and activated in many human tumors and caused a rapid decrease in the Ezh2 Polycomb cancers, including breast cancer, and its activation group histone H3K27 methyltransferase and an increase generally correlates with poor prognosis. Nonetheless, in epithelial organization. SKI-606 prevented the appear- biomarkers predictive of a clinical response remain elusive. ance of palpable tumors in over 50% of the animals and The Src inhibitors dasatinib, saracatinib (AZD0530) stopped tumor growth in older animals with pre-existing and SKI-606 (bosutinib) are in phase II of clinical tumors. These antitumor effects were accompanied by development for the treatment of solid tumors of decreased cellular proliferation, altered tumor blood vessel metastatic breast and prostate cancer. SKI-606, a organization and dramatically increased differentiation multikinase inhibitor originally identified as an Src to lactational and epidermal cell fates. SKI-606 controls and Abl kinase inhibitor, is effective in vitro on the development of mammary tumors by inducing colorectal and breast tumor cells, chronic myelogenous differentiation. leukemia cells and also in multiple xenotransplantation Oncogene (2011) 30, 301–312; doi:10.1038/onc.2010.412; experiments (Boschelli et al., 2001; Jallal et al., 2007; published online 6 September 2010 Vultur et al., 2008). Src inhibitors generally have subtle effects on tumor cells under normal culture conditions Keywords: Src; SKI-606; mouse; breast cancer; Ezh2 (Golas et al., 2005; Vultur et al., 2008). The effects of SKI-606 in models of developing breast cancer have not been reported. The many functions of Src and Src family kinases in multiple signaling pathways suggest that the effects of inhibiting Src should be integrated into a whole- Correspondence: Professor RG Oshima, Tumor Development, Cancer animal context with a fully functional immune system Research Center, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. (Finn, 2008). The Src-dependent, immunocompetent, E-mails: [email protected] or [email protected] autochthonous FVB/N-Tg(MMTV-PyVmT)634Mul 7Formerly Burnham Institute for Medical Research. (MMTV-PyMT) breast cancer mouse model is an ideal 8Formerly Wyeth Oncology Discovery Research. tool for such a study because it permits the evaluation of 9Current address: Westmead Millennium Institute, Storr Liver Unit, Westmead NSW 2145, Australia. both early and late stages of luminal-type metastatic Received 26 April 2010; revised 28 July 2010; accepted 2 August 2010; carcinomas (Guy et al., 1992; Lin et al., 2003). This published online 6 September 2010 model mimics changes associated with human breast SKI-606 induced tumor differentiation L Hebbard et al 302 cancer progression, including upregulation of cyclinD1 SKI-606 accumulates in tumor tissue and inhibits Src and HER2, and infiltration of leukocytes. PyMT- activity induced mammary tumors are dependent on multiple Previously published data indicated that orally adminis- signaling molecules, including c-Src, phosphatidylinosi- tered SKI-606 was well distributed in the tissues of nude tol-3-kinase, Shc and insulin/insulin-like growth factor-1 mice and accumulated in human tumor xenografts. receptors (Ishizawar and Parsons, 2004). Analysis of plasma obtained from MMTV-PyMT Genetic inactivation of the c-src gene in MMTV- tumor-bearing mice 18 h after a single oral dose of PyMT mice limits the effect of PyMT transgene SKI-606 revealed plasma concentrations of 321 ng/ml expression on formation of hyperplastic lesions in (604 nM), well above the concentration effectively mammary tissues after a long latency period with inhibiting Src kinase activity (Boschelli et al., 2001) activated levels of c-Yes, a closely related member of and well within the range required to inhibit breast the Src family of kinases (Guy et al., 1994). c-Src cancer tumor cell growth and invasion in cell culture activation by PyMT is not the sole driver for tumor- (Jallal et al., 2007; Vultur et al., 2008) (Figure 1c). In igenesis, as expressing activated Src under the MMTV addition, SKI-606 accumulates in PyMT tumors to a promoter in the absence of PyMT leads to defective concentration of 2477 ng/g of tumor (Figure 1c). We mammary development and hyperplasia, but not in- determined the relative levels of active Src in these vasive tumor formation (Webster et al., 1995). Similarly, tumors by monitoring the phosphorylation of Y418 18 h when PyMT is mutated to block either SHC or PI3- following SKI-606 administration. SKI-606 treatment kinase association, only hyperplastic lesions are formed reduced P-Y418 levels in PyMT tumors by 75% of the (Webster et al., 1998), unless an angiogenic stimulus levels observed in tumors from vehicle-treated animals such as vascular endothelial growth factor (VEGF) is (Figure 1d), suggesting that SKI-606 inhibits the provided (Oshima et al., 2004). intended molecular target. Our studies show that SKI-606 treatment suppressed both early hyperplastic stages of the disease and overt tumor development. SKI-606 treatment stopped growth SKI-606 suppresses mammary tumor appearance of established tumors by inducing dysplastic differentia- PyMT expression occurs about 4 weeks after birth upon tion of tumor cells and altered vascular organization. mammary gland development at sexual maturity. The These responses were accompanied by downregulation mammary epithelial tree of MMTV-PyMT adolescent of the Polycomb repressor complex 2 subunit EZH2. females develops a small tumor-like mass beneath the The control of this aggressive model of breast cancer by nipple area concurrent with the emergence of the normal differentiation suggests that different clinical end points epithelial branching tubes (Neznanov et al., 1999; might be considered to evaluate drugs that control Maglione et al., 2001). Next focal hyperplastic lesions cancer through differentiation rather than cell death. arise among the normal epithelial structures, which then progress to mammary intraepithelial neoplasia and later to invasive cancer (Maglione et al., 2001; Lin et al., 2003). Results To test the effect of SKI-606 on both early hyperplastic lesions and mammary epithelial develop- SKI-606 inhibits cell growth in culture without inducing ment, SKI-606 (150 mg/kg) was administered by oral cell death gavage to female transgenic mice aged 30±2 days once Previous studies indicated that treatment with 1 mm daily for 14 days. SKI-606 treatment was very effective SKI-606 significantly reduced phosphorylation of the in limiting the growth of hyperplastic lesions and Y418 gatekeeper residue of c-Src in human tumor cells mammary intraepithelial neoplasia to less than 40% of (Golas et al., 2005; Vultur et al., 2008). To determine the size of lesions in the vehicle-treated control group whether SKI-606 affected in vitro growth of PyMT- (Supplementary Figures S1A and S1C). In contrast, transformed mammary tumor cells, Py-230 cells were the normal mammary epithelial ductal and endbud treated with SKI-606 at various concentrations. In a structures appeared fully extended to the distal limits 4-day assay, submicromolar concentrations of SKI-606 of the fat pad. This indicates that SKI-606 did not inhibited Py-230 cell proliferation (Figure 1a). However, interfere with the normal invasion and branching of Py-230 cells formed colonies from single cells in the the mammary gland while restricting abnormal hyper- presence of up to 750 nM SKI-606 (Figure 1a), but colony plastic growth.
Load more

Recommended publications
  • The Snf1-Related Kinase, Hunk, Is Essential for Mammary Tumor Metastasis
    The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis Gerald B. W. Wertheima, Thomas W. Yanga, Tien-chi Pana, Anna Ramnea, Zhandong Liua, Heather P. Gardnera, Katherine D. Dugana, Petra Kristelb, Bas Kreikeb, Marc J. van de Vijverb, Robert D. Cardiffc, Carol Reynoldsd, and Lewis A. Chodosha,1 aDepartments of Cancer Biology, Cell and Developmental Biology, and Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160; bDepartment of Diagnostic Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; cCenter for Comparative Medicine, University of California, County Road 98 and Hutchison Drive, Davis, CA 95616; and dDivision of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905 Communicated by Craig B. Thompson, University of Pennsylvania, Philadelphia, PA, July 27, 2009 (received for review April 22, 2009) We previously identified a SNF1/AMPK-related protein kinase, Hunk, Results from a mammary tumor arising in an MMTV-neu transgenic mouse. Hunk Is Overexpressed in Aggressive Subsets of Human Cancers. To The function of this kinase is unknown. Using targeted deletion in investigate its role in human tumorigenesis, we cloned the human mice, we now demonstrate that Hunk is required for the metastasis homologue of Hunk from a fetal brain cDNA library. Sequence of c-myc-induced mammary tumors, but is dispensable for normal analysis yielded a composite cDNA spanning an ORF of 714 amino development. Reconstitution experiments revealed that Hunk is suf- acids (GenBank accession #NM࿝014586). Review of this sequence ficient to restore the metastatic potential of Hunk-deficient tumor and of human genome data indicated that a single Hunk isoform cells, as well as defects in migration and invasion, and does so in a exists that is 92% identical to murine Hunk at the amino acid level manner that requires its kinase activity.
    [Show full text]
  • Genetic Background Effects of Keratin 8 and 18 in a DDC-Induced Hepatotoxicity and Mallory-Denk Body Formation Mouse Model
    Laboratory Investigation (2012) 92, 857–867 & 2012 USCAP, Inc All rights reserved 0023-6837/12 $32.00 Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model Johannes Haybaeck1, Cornelia Stumptner1, Andrea Thueringer1, Thomas Kolbe2, Thomas M Magin3, Michael Hesse4, Peter Fickert5, Oleksiy Tsybrovskyy1, Heimo Mu¨ller1, Michael Trauner5,6, Kurt Zatloukal1 and Helmut Denk1 Keratin 8 (K8) and keratin 18 (K18) form the major hepatocyte cytoskeleton. We investigated the impact of genetic loss of either K8 or K18 on liver homeostasis under toxic stress with the hypothesis that K8 and K18 exert different functions. krt8À/À and krt18À/À mice crossed into the same 129-ola genetic background were treated by acute and chronic ad- ministration of 3,5-diethoxy-carbonyl-1,4-dihydrocollidine (DDC). In acutely DDC-intoxicated mice, macrovesicular steatosis was more pronounced in krt8À/À and krt18À/À compared with wild-type (wt) animals. Mallory-Denk bodies (MDBs) appeared in krt18À/À mice already at an early stage of intoxication in contrast to krt8À/À mice that did not display MDB formation when fed with DDC. Keratin-deficient mice displayed significantly lower numbers of apoptotic hepatocytes than wt animals. krt8À/À, krt18À/À and control mice displayed comparable cell proliferation rates. Chronically DDC-intoxicated krt18À/À and wt mice showed a similarly increased degree of steatohepatitis with hepatocyte ballooning and MDB formation. In krt8À/À mice, steatosis was less, ballooning, and MDBs were absent. krt18À/À mice developed MDBs whereas krt8À/À mice on the same genetic background did not, highlighting the significance of different structural properties of keratins.
    [Show full text]
  • Identification of Trichoplein, a Novel Keratin Filament- Binding Protein
    Research Article 1081 Identification of trichoplein, a novel keratin filament- binding protein Miwako Nishizawa1,*, Ichiro Izawa1,*, Akihito Inoko1,*, Yuko Hayashi1, Koh-ichi Nagata1, Tomoya Yokoyama1,2, Jiro Usukura3 and Masaki Inagaki1,‡ 1Division of Biochemistry, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan 2Department of Dermatology, Mie University Faculty of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan 3Department of Anatomy and Cell Biology, Nagoya University School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan *These authors contributed equally to this work ‡Author for correspondence (e-mail: [email protected]) Accepted 29 November 2004 Journal of Cell Science 118, 1081-1090 Published by The Company of Biologists 2005 doi:10.1242/jcs.01667 Summary Keratins 8 and 18 (K8/18) are major components of the antibody in a complex with K8/18 and immunostaining intermediate filaments (IFs) of simple epithelia. We report revealed that trichoplein colocalized with K8/18 filaments here the identification of a novel protein termed in HeLa cells. In polarized Caco-2 cells, trichoplein trichoplein. This protein shows a low degree of sequence colocalized not only with K8/18 filaments in the apical similarity to trichohyalin, plectin and myosin heavy chain, region but also with desmoplakin, a constituent of and is a K8/18-binding protein. Among interactions desmosomes. In the absorptive cells of the small intestine, between trichoplein and various IF proteins that we trichoplein colocalized with K8/18 filaments at the apical tested using two-hybrid methods, trichoplein interacted cortical region, and was also concentrated at desmosomes.
    [Show full text]
  • Surgically-Induced Multi-Organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer
    ANTICANCER RESEARCH 35: 4641-4646 (2015) Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer YONG ZHANG1, NAN ZHANG1, ROBERT M. HOFFMAN1,2 and MING ZHAO1 1AntiCancer, Inc., San Diego, CA, U.S.A.; 2Department of Surgery, University of California, San Diego, CA, U.S.A. Abstract. Background/Aim: Murine models of breast cancer When implanted orthotopically, 4T1 has been shown to with a metastatic pattern similar to clinical breast cancer in metastasize to organs similarly to clinical breast cancer in humans would be useful for drug discovery and mechanistic humans, including to lungs, liver, brain and bone (3-6). Tao studies. The 4T1 mouse breast cancer cell line was developed et al. transformed the 4T1 cell line to express luciferase for by Miller et al. in the early 1980s to study tumor metastatic longitudinal detection of primary growth and metastases (7). heterogeneity. The aim of the present study was to develop a In their study, metastasis at high rates, including the lungs, multi-organ-metastasis imageable model of 4T1. Materials and liver and bone, occurred in most animals within six weeks Methods: A stable 4T1 clone highly-expressing red fluorescent with lower frequency of metastasis to brain and other sites. protein (RFP) was injected orthotopically into the right second This imageable model is limited by the weak signal of mammary fat pad of BALB/c mice. The primary tumor was luciferase which requires photon-counting of anesthetized resected on day 18 after tumor implantation, when the average animals. The weak signal of luciferase cannot produce a true tumor volume reached approximately 500-600 mm3.
    [Show full text]
  • Keratins Couple with the Nuclear Lamina and Regulate Proliferation in Colonic Epithelial Cells Carl-Gustaf A
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.22.164467; this version posted June 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Keratins couple with the nuclear lamina and regulate proliferation in colonic epithelial cells Carl-Gustaf A. Stenvall1*, Joel H. Nyström1*, Ciarán Butler-Hallissey1,5, Stephen A. Adam2, Roland Foisner3, Karen M. Ridge2, Robert D. Goldman2, Diana M. Toivola1,4 1 Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland 2 Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA 3 Max Perutz Labs, Medical University of Vienna, Vienna Biocenter Campus (VBC), Vienna, Austria 4 Turku Center for Disease Modeling, Turku, Finland 5 Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland * indicates equal contribution Running Head: Colonocyte keratins couple to nuclear lamina Corresponding author: Diana M. Toivola Cell Biology/Biosciences, Faculty of Science and Engineering, Åbo Akademi University Tykistökatu 6A, FIN-20520 Turku, Finland Telephone: +358 2 2154092 E-mail: [email protected] Keywords: Keratins, lamin, intermediate filament, colon epithelial cells, LINC proteins, proliferation, pRb, YAP bioRxiv preprint doi: https://doi.org/10.1101/2020.06.22.164467; this version posted June 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Pflugers Final
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Serveur académique lausannois A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule. Sylvain Pradervand2, Annie Mercier Zuber1, Gabriel Centeno1, Olivier Bonny1,3,4 and Dmitri Firsov1,4 1 - Department of Pharmacology and Toxicology, University of Lausanne, 1005 Lausanne, Switzerland 2 - DNA Array Facility, University of Lausanne, 1015 Lausanne, Switzerland 3 - Service of Nephrology, Lausanne University Hospital, 1005 Lausanne, Switzerland 4 – these two authors have equally contributed to the study to whom correspondence should be addressed: Dmitri FIRSOV Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925406 Fax: ++ 41-216925355 e-mail: [email protected] and Olivier BONNY Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925417 Fax: ++ 41-216925355 e-mail: [email protected] 1 Abstract The distal parts of the renal tubule play a critical role in maintaining homeostasis of extracellular fluids. In this review, we present an in-depth analysis of microarray-based gene expression profiles available for microdissected mouse distal nephron segments, i.e., the distal convoluted tubule (DCT) and the connecting tubule (CNT), and for the cortical portion of the collecting duct (CCD) (Zuber et al., 2009). Classification of expressed transcripts in 14 major functional gene categories demonstrated that all principal proteins involved in maintaining of salt and water balance are represented by highly abundant transcripts. However, a significant number of transcripts belonging, for instance, to categories of G protein-coupled receptors (GPCR) or serine-threonine kinases exhibit high expression levels but remain unassigned to a specific renal function.
    [Show full text]
  • Canine Mammary Carcinoma
    Oncology Services Lloyd Veterinary Medical Center Hixson-Lied Small Animal Hospital Canine Mammary Carcinoma What is a canine mammary carcinoma? Tumors of the mammary gland develop when the cells associated with the mammary gland become cancerous and grow uncontrollably. In dogs, approximately 50% of mammary tumors are malignant (have the potential to spread to other areas of the body). The other half are considered to be benign. The most common type of malignant mammary tumor is a carcinoma. What are the clinical signs of a mammary tumor? This tumor is often identified during a routine physical exam, or you may notice it at home. They usually manifest as a swelling of the mammary gland or the nearby tissues/skin. They can be firm or soft. How is a mammary tumor diagnosed? Biopsy is required to diagnose a mammary gland tumor. Prior to making definitive treatment options, full staging with an abdominal ultrasound, chest x-rays, and evaluation of the local lymph nodes are recommended to look for any spread of disease. How is a mammary tumor treated? Treatment of mammary tumors is aimed at both local control (removing the primary tumor and minimizing the likelihood of local recurrence) and systemic control (delaying the onset of spread of disease). Each tumor should be removed with a wide band of normal tissue around the tumor to result in the best possible outcome. If this type of surgery is not possible, a combination of surgery and radiation therapy may be discussed. Based on the type of tumor, and several factors evaluated on biopsy, chemotherapy may be recommended in addition to surgical removal.
    [Show full text]
  • Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser
    Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser January 2016 Supervisors: BM Corfe and KS Chapple Department of Oncology Thesis submitted to the University of Sheffield for the degree of Doctor of Medicine 2 Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Table of Contents Abstract ................................................................................................................................. 7 Acknowledgments ............................................................................................................. 9 List of Figures ................................................................................................................... 11 List of Tables .................................................................................................................... 13 Abbreviations .................................................................................................................. 15 Chapter 1 Literature review ....................................................................................... 19 1.1 The History of Adenomatous polyps ................................................................. 19 1.1.1 Origins of the Adenoma ............................................................................................... 20 1.1.2 Adenoma-Carcinogenesis model ......................................................................................... 24 1.2 Field effects – Theory and Definitions .............................................................
    [Show full text]
  • Biological Functions of Cytokeratin 18 in Cancer
    Published OnlineFirst March 27, 2012; DOI: 10.1158/1541-7786.MCR-11-0222 Molecular Cancer Review Research Biological Functions of Cytokeratin 18 in Cancer Yu-Rong Weng1,2, Yun Cui1,2, and Jing-Yuan Fang1,2,3 Abstract The structural proteins cytokeratin 18 (CK18) and its coexpressed complementary partner CK8 are expressed in a variety of adult epithelial organs and may play a role in carcinogenesis. In this study, we focused on the biological functions of CK18, which is thought to modulate intracellular signaling and operates in conjunction with various related proteins. CK18 may affect carcinogenesis through several signaling pathways, including the phosphoinosi- tide 3-kinase (PI3K)/Akt, Wnt, and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) signaling pathways. CK18 acts as an identical target of Akt in the PI3K/Akt pathway and of ERK1/2 in the ERK MAPK pathway, and regulation of CK18 by Wnt is involved in Akt activation. Finally, we discuss the importance of gaining a more complete understanding of the expression of CK18 during carcinogenesis, and suggest potential clinical applications of that understanding. Mol Cancer Res; 10(4); 1–9. Ó2012 AACR. Introduction epithelial organs, such as the liver, lung, kidney, pancreas, The intermediate filaments consist of a large number of gastrointestinal tract, and mammary gland, and are also nuclear and cytoplasmic proteins that are expressed in a expressed by cancers that arise from these tissues (7). In the tissue- and differentiation-dependent manner. The compo- absence of CK8, the CK18 protein is degraded and keratin fi intermediate filaments are not formed (8).
    [Show full text]
  • Suppression Ofautochthonous Grafts Ofspontaneous Mammary Tumor by Induced Allogeneic Graft Rejection Mechanism
    [CANCER RESEARCH 33, 645-647, April 1973] Suppression of Autochthonous Grafts of Spontaneous Mammary Tumor by Induced Allogeneic Graft Rejection Mechanism Reiko Tokuzen and Waro Nakahara National Cancer Center Research Institute, Tsukiji 5-chome, Chuo-ku, Tokyo, Japan SUMMARY existing between the allogeneic and autochthonous grafts are involved in determining the different susceptibilities to the Autochthonous grafts of spontaneous mammary adenocar- host-mediated antitumor effect of plant polysaccharides. cinoma of mice give 100% takes with no spontaneous More recently, we examined local cellular reactions around regression. However, the growth of these autografts was Sarcoma 180 grafts during the process of regression under markedly inhibited with a high rate of complete regression polysaccharide treatment, and we found a massive outpouring when the grafts were mixed with ascitic Sarcoma 180 and of lymphoid cells 1 week after tumor implantation. No such implanted under i.p. treatment with lentinan. Lentinan is one cellular reaction was noted in untreated controls or in mice of the so-called antitumor-active plant polysaccharides; it treated with inactive polysaccharides. Similarly, autoch strongly inhibits Sarcoma 180 but has no effect on thonous grafts of spontaneous mammary tumors, not at all autochthonous grafts. Without the lentinan treatment, the inhibited by polysaccharides, called forth no local lymphoid mixed autografts and Sarcoma 180 or Sarcoma 180 alone cell infiltration. constantly produced large tumors. These results indicate that a The question arose as to what would happen to autoch local rejection mechanism against allogeneic tumor (Sarcoma thonous grafts if such local cell reaction were induced around 180), induced by injections of lentinan, failed to recognize them as in that which occurred around Sarcoma 180 under autografts as "self and destroyed them along with the polysaccharide treatment.
    [Show full text]
  • Keratin Gene Expression in Non-Epithelial Tissues Detection with Polymerase Chain Reaction
    American Journal ofPathology, Vol. 142, No. 4, April 1993 Copyright C American Societyfor Investigative Pathology Keratin Gene Expression in Non-Epithelial Tissues Detection with Polymerase Chain Reaction S. Thomas Traweek, Jane Liu, and ceUs, or any of the seven normal bone marrows Hector Battifora examined. Dilutional experiments showedPCR to From the Sylvia Cowan Laboratory ofSurgical Pathology, be highly sensitive in the detection of keratin 19 Division ofPathology, City ofHope National Medical gene expression, capable of registering one Center, Duarte, California MCF-7 ceU in 106 HL-60 ceUs. These studies show that variable levels of keratin 8 and 18 gene ex- pression may be detected by PCR in a wide varlety ofnon-epithelial tissues, supportlingprevious im- Keratinfilament are characteristicaly present in munohistochemical and phylogenetic studies. epithelial ceUs and tumors, but have also been de- However, keratin 19 gene expression appears to tected in many normal and neoplastic non- be more restricted and was not evident in any he- epithelial ceU types using immunohistochemical matopoietic ceUs devoid of contaminating stro- techniques. To investigate the validity of this mal elements. these flndings suggest a role for seemingly aberrant protein expression, we ap- PCR in the detection ofepithelialmicrometastasis plied the highly sensitivepolymerase chain reac- in certain sites, particularly bone marrow. (Am tion (PCR) technique to study keratin gene ex- JPathol 1993, 142:1111-1118) pression in a variety of non-epithelial tissues. Total RNA was extracted from nine samples of leiomyosarcoma, four non-Hodgkin's lymphoma, Intermediate filaments (IF) are the principal compo- seven normal bone marrows, normal lymph node, nents of the cytoskeleton in mammalian cells.
    [Show full text]
  • Understanding the Etiology of Inflammatory Breast
    UNDERSTANDING THE ETIOLOGY OF INFLAMMATORY BREAST CANCER by Lauren M. Shuman A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Master of Science in Biological Sciences Spring 2015 © 2015 Lauren M. Shuman All Rights Reserved ProQuest Number: 1596894 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. ProQuest 1596894 Published by ProQuest LLC (2015). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, MI 48106 - 1346 UNDERSTANDING THE ETIOLOGY OF INFLAMMATORY BREAST CANCER by Lauren M. Shuman Approved: ____________________________________________________ Kenneth L. van Golen, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: ____________________________________________________ Robin W. Morgan, Ph.D. Chair of the Department of Biological Sciences Approved: ____________________________________________________ George H. Watson, Ph.D. Dean of the College of Arts and Sciences Approved: ____________________________________________________ James G. Richards, Ph.D. Vice Provost for Graduate and Professional Education ACKNOWLEDGMENTS First and foremost, I would like to thank Dr. Kenneth van Golen for a list of things, but namely for the opportunity to work in this lab that gave me my first experience in cancer research.
    [Show full text]